AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2012
Sep 24, 2012
34117_dirs_2012-09-24_1006328b-b807-45d1-aa74-7a243eaee19c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2012-09-21
Reporting Person: HERMS HENRY P (Director, VP - Finance & CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-09-19 | Employee Stock Option | $0.235 | A | 300000 | Acquired | 2022-09-19 | Common Stock (300000) | Direct |
Footnotes
F1: Right-To-Buy, pursuant to the CopyTele, Inc. 2010 Share Incentive Plan.
F2: The option vests in 36 equal monthly installments beginning on 10/31/2012.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6